Relapsing Polychondritis
📧 Sign up to get email alerts when something new happens for Relapsing Polychondritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis [Phase 2]
This update reports results from a Phase 2 trial of a biologic therapy for refractory primary non-ANCA associated vasculitis; the study was …
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis [Phase 2]
Phase 2 clinical trial update evaluating low-dose recombinant human IL-2 for relapsing polychondritis has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab [NA]
A single-patient study evaluating tocilizumab for relapsing polychondritis has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Study on the Safety of Abatacept in Relapsing Polychondritis [Phase 1]
Phase 1 study assessing the safety of abatacept in relapsing polychondritis has completed.